Filing Details
- Accession Number:
- 0000899243-19-018907
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-07-02 17:10:57
- Reporting Period:
- 2019-07-02
- Accepted Time:
- 2019-07-02 17:10:57
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1771917 | Karuna Therapeutics Inc. | KRTX | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1245624 | James Healy | Sofinnova Investments, Inc. 3000 Sand Hill Road, 4-250 Menlo Park CA 94025 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2019-07-02 | 1,029,352 | $0.00 | 1,029,352 | No | 4 | C | Indirect | By Sofinnova Venture Partners X, L.P. |
Common Stock | Acquisiton | 2019-07-02 | 700,000 | $16.00 | 1,729,352 | No | 4 | P | Indirect | By Sofinnova Venture Partners X, L.P. |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Indirect | By Sofinnova Venture Partners X, L.P. |
No | 4 | P | Indirect | By Sofinnova Venture Partners X, L.P. |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series B Preferred Stock | Disposition | 2019-07-02 | 792,602 | $0.00 | 1,029,352 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Indirect |
Footnotes
- The Series B Preferred Stock is convertible into shares of the Issuer's Common Stock on a 1.2987-for-one basis. Upon the closing of the Issuer's initial public offering, all shares of Series B Preferred Stock automatically converted into shares of Common Stock. The Series B Preferred Stock has no expiration date.
- All shares held by Sofinnova Venture Partners X, L.P. ("SVP X"). Sofinnova Management X, L.L.C. ("SM X"), the general partner of SVP X, may be deemed to have sole voting power, and Dr. Michael F. Powell, Dr. James I. Healy, and Dr. Anand Mehra, the managing members of SM X, may be deemed to have shared power to vote these shares. Such individuals disclaim beneficial ownership of such shares except to the extent of their pecuniary interest therein.